US Patent Issued to CENTRE EUROPEEN D'ETUDE DU DIABETE on Dec. 30 for "Decorin for its use in the treatment of diabetes" (French Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,301, issued on Dec. 30, was assigned to CENTRE EUROPEEN D'ETUDE DU DIABETE (Strasbourg, France).

"Decorin for its use in the treatment of diabetes" was invented by Karim Bouzakri (Truchtersheim, France) and Michel Pinget (Bernolsheim, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Decorin or a composition containing decorin for use in the treatment of type 1 diabetes, type 2 diabetes or gestational diabetes is described herein. Decorin or a composition containing decorin is also described for use in the context of transplanting pancreatic islet cells."

The patent was filed on Dec. 19, 2019, under Application No. 17/416,130.

*For further inf...